NEOGENOMICS INC — Director's Dealing 2017

Jan 4, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2017-01-03

Reporting Person: Johnson Kevin C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-01-03	Common Stock	M	3333	$4.78	Acquired	121087	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-01-03	Stock Option (Right to Buy)	$4.78	X	3333	Disposed	2020-05-06	Common Stock (3333)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Restricted Stock	$	2017-03-31	Common Stock (2150)	2150	Direct
Restricted Stock	$	2017-03-31	Common Stock (5072)	7222	Direct
Stock Option (Right to Buy)	$9.11	2021-07-28	Common Stock (8333)	15555	Direct
Stock Option (Right to Buy)	$4.78	2020-05-06	Common Stock (10000)	25555	Direct

Footnotes

F1: Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.

F2: 537.5 shares will vest on June 30, 2016 and thereafter, 537.5 shares will vest on the last day of each calendar quarter for the next three fiscal quarters up to March 31, 2017.

F3: 1,690.6 shares will vest on September 30, 2016 and thereafter, 1,690.7 shares will vest on the last day of each calendar quarter for the next two fiscal quarters up to March 31, 2017.

F4: On July 28, 2016, Mr. Johnson was granted 8,333 stock options. The options vest ratably over the first three anniversary dates of the grant date.

F5: On May 6, 2015 Mr. Johnson was granted 10,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.